ICU Medical Stock Hits New 52-Week High (ICUI)

NEW YORK ( TheStreet) -- ICU Medical (Nasdaq: ICUI) hit a new 52-week high Wednesday as it is currently trading at $50.94, above its previous 52-week high of $50.43 with 8,958 shares traded as of 9:49 a.m. ET. Average volume has been 79,700 shares over the past 30 days.

ICU Medical has a market cap of $686.3 million and is part of the health care sector and health services industry. Shares are up 11% year to date as of the close of trading on Tuesday.

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in infusion therapy, oncology, and critical care applications. The company has a P/E ratio of 15.6, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates ICU Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full ICU Medical Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

These 5 Health Care Stocks Are Breaking Out This Christmas

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report